These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 7561039)
1. Distinct phenotypes of antigen-selected CD8 T cells emerge at different stages of an in vivo immune response. Walker PR; Ohteki T; Lopez JA; MacDonald HR; Maryanski JL J Immunol; 1995 Oct; 155(7):3443-52. PubMed ID: 7561039 [TBL] [Abstract][Full Text] [Related]
2. Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization. Bour H; Horvath C; Lurquin C; Cerottini JC; MacDonald HR J Immunol; 1998 Jun; 160(11):5522-9. PubMed ID: 9605156 [TBL] [Abstract][Full Text] [Related]
3. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo. Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422 [TBL] [Abstract][Full Text] [Related]
4. Functional similarity and differences between selection-independent CD4-CD8- alphabeta T cells and positively selected CD8 T cells expressing the same TCR and the induction of anergy in CD4-CD8- alphabeta T cells in antigen-expressing mice. Caveno J; Zhang Y; Motyka B; Teh SJ; Teh HS J Immunol; 1999 Aug; 163(3):1222-9. PubMed ID: 10415017 [TBL] [Abstract][Full Text] [Related]
5. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer. Bristol JA; Schlom J; Abrams SI Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883 [TBL] [Abstract][Full Text] [Related]
6. MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response. Leite-de-Moraes MC; Herbelin A; Machavoine F; Vicari A; Gombert JM; Papiernik M; Dy M J Immunol; 1995 Nov; 155(10):4544-50. PubMed ID: 7594451 [TBL] [Abstract][Full Text] [Related]
7. Tumor-derived interleukin-4 reduces tumor clearance and deviates the cytokine and granzyme profile of tumor-induced CD8+ T cells. Olver S; Groves P; Buttigieg K; Morris ES; Janas ML; Kelso A; Kienzle N Cancer Res; 2006 Jan; 66(1):571-80. PubMed ID: 16397274 [TBL] [Abstract][Full Text] [Related]
8. Qualitative differences between naive and memory T cells make a major contribution to the more rapid and efficient memory CD8+ T cell response. Kedl RM; Mescher MF J Immunol; 1998 Jul; 161(2):674-83. PubMed ID: 9670942 [TBL] [Abstract][Full Text] [Related]
9. Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization. Bristol JA; Orsini C; Lindinger P; Thalhamer J; Abrams SI Cell Immunol; 2000 Nov; 205(2):73-83. PubMed ID: 11104579 [TBL] [Abstract][Full Text] [Related]
10. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen. Curtsinger JM; Lins DC; Mescher MF J Immunol; 1998 Apr; 160(7):3236-43. PubMed ID: 9531279 [TBL] [Abstract][Full Text] [Related]
11. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites. Meraldi V; Romero JF; Kensil C; Corradin G Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728 [TBL] [Abstract][Full Text] [Related]
12. Positive selection of thymocytes expressing the same TCR by different MHC ligands results in the production of functionally distinct thymocytes distinguished by differential expression of the heat stable antigen. Teh HS; Motyka B; Teh SJ J Immunol; 1998 Jan; 160(2):718-27. PubMed ID: 9551907 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of CD8 on mature antigen-reactive T cells as a mechanism of peripheral tolerance. Zhang L; Fung-Leung W; Miller RG J Immunol; 1995 Oct; 155(7):3464-71. PubMed ID: 7561041 [TBL] [Abstract][Full Text] [Related]
14. Expression in vivo of CD45RA, CD45RB and CD44 on T cell receptor-transgenic CD8+ T cells following immunization. Pihlgren M; Lightstone L; Mamalaki C; Rimon G; Kioussis D; Marvel J Eur J Immunol; 1995 Jun; 25(6):1755-9. PubMed ID: 7542202 [TBL] [Abstract][Full Text] [Related]
15. Phenotypic characteristics associated with the acquisition of HSV-specific CD8 T-lymphocyte-mediated cytolytic function in vitro. McNally JM; Andersen HA; Chervenak R; Jennings SR Cell Immunol; 1999 May; 194(1):103-11. PubMed ID: 10357886 [TBL] [Abstract][Full Text] [Related]
16. Unique phenotype and distinct TCR V beta repertoire in human peripheral blood alpha beta TCR+, CD4-, and CD8- double negative T cells. Niehues T; Gulwani-Akolkar B; Akolkar PN; Tax W; Silver J J Immunol; 1994 Feb; 152(3):1072-81. PubMed ID: 8301117 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract. Bharhani MS; Grewal JS; Peppler R; Enockson C; London L; London SD Int Immunol; 2007 Apr; 19(4):567-79. PubMed ID: 17369189 [TBL] [Abstract][Full Text] [Related]
18. Distribution of Ly-6C on lymphocyte subsets: I. Influence of allotype on T lymphocyte expression. Schlueter AJ; Malek TR; Hostetler CN; Smith PA; deVries P; Waldschmidt TJ J Immunol; 1997 May; 158(9):4211-22. PubMed ID: 9126982 [TBL] [Abstract][Full Text] [Related]
19. CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response. Peixoto A; Evaristo C; Munitic I; Monteiro M; Charbit A; Rocha B; Veiga-Fernandes H J Exp Med; 2007 May; 204(5):1193-205. PubMed ID: 17485515 [TBL] [Abstract][Full Text] [Related]
20. Retroviral transduction of protein kinase C-gamma into tumor-specific T cells allows antigen-independent long-term growth in IL-2 with retention of functional specificity in vitro and ability to mediate tumor therapy in vivo. Chen W; Schweins E; Chen X; Finn OJ; Cheever MA J Immunol; 1994 Oct; 153(8):3630-8. PubMed ID: 7930583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]